Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Bendamustine Hydrochloride × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 28 Lymphoma, Non-Hodgkin 25 Multiple Myeloma 16 Lymphoma 15 Lymphoma, Mantle-Cell 14 Lymphoma, Follicular 14 Lymphoma, Large B-Cell, Diffuse 11 Hodgkin Disease 7 Recurrence 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia 5 Neoplasms, Plasma Cell 4 Waldenstrom Macroglobulinemia 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Lymphoid 3 Small Cell Lung Carcinoma 2 Neoplasms 2 Hematologic Diseases 2 Tumor Lysis Syndrome 1 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡